• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TRIVIDIA HEALTH, INC. SYRINGES; BLOOD GLUCOSE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TRIVIDIA HEALTH, INC. SYRINGES; BLOOD GLUCOSE SYSTEM Back to Search Results
Model Number SYRINGES
Device Problem Material Twisted/Bent (2981)
Patient Problem Skin Tears (2516)
Event Date 06/10/2019
Event Type  malfunction  
Manufacturer Narrative
(manufacturer narrative = t, corrected data = f) internal report: (b)(4).Syringes were not returned for evaluation.Most likely underlying root cause: mlc-61: improper use / mishandled by end user.Note: manufacturer contacted customer in a follow-up call to ensure that the replacement products resolved the initial concern - able unable to establish contact with customer at this time.
 
Event Description
Consumer reported complaint for syringe needle broken/warped.The customer did report skin ripping and bleeding.Medical attention is not reported as a result.The product storage location is undisclosed.The syringe lot manufacturer's expiration date is undisclosed and open vial date is undisclosed.
 
Manufacturer Narrative
(manufacturer narrative = t, corrected data = f) internal report: (b)(4).Syringes were not returned for evaluation.Most likely underlying root cause: mlc-61: improper use / mishandled by end user.Note: manufacturer contacted customer in a follow-up call to ensure that the replacement products resolved the initial concern - unable to establish contact with customer at this time.Product notification letter sent to contact customer care.
 
Event Description
Consumer reported complaint for syringe needle broken/warped.The customer did report skin ripping and bleeding.Medical attention is not reported as a result.The product storage location is undisclosed.The syringe lot manufacturer's expiration date is undisclosed and open vial date is undisclosed.
 
Event Description
Consumer reported complaint for syringe needle broken/warped.The customer did report skin ripping and bleeding.Medical attention is not reported as a result.The product storage location is undisclosed.The syringe lot manufacturer's expiration date is undisclosed and open vial date is undisclosed.
 
Manufacturer Narrative
(manufacturer narrative = t, corrected data = f) internal report: (b)(4) syringes were returned for evaluation.Most likely underlying root cause: mlc-61: improper use / mishandled by end user.Note: manufacturer contacted customer in a follow-up call to ensure that the replacement products resolved the initial concern - unable to establish contact with customer at this time.Product notification letter sent to contact customer care.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYRINGES
Type of Device
BLOOD GLUCOSE SYSTEM
Manufacturer (Section D)
TRIVIDIA HEALTH, INC.
2400 nw 55th court
fort lauderdale FL 33309
MDR Report Key8745735
MDR Text Key151001880
Report Number1000113657-2019-00692
Device Sequence Number1
Product Code FMF
Combination Product (y/n)N
PMA/PMN Number
K993017
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Remedial Action Other
Type of Report Initial,Followup,Followup
Report Date 07/23/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/28/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberSYRINGES
Device Lot NumberNP18088
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/18/2019
Was the Report Sent to FDA? No
Event Location Home
Date Manufacturer Received06/10/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
SECOND THERAPY; SECOND THERAPY; SECOND THERAPY
-
-